Advancing Global Equitable Access to Vaccines: Intellectual Property, Technology Transfer and Contracts
Although Covid-19 vaccines were developed at an astounding speed, there was a major gap between high-income and low and middle-income countries (LMICs) in the timely access to medical countermeasures during the pandemic. Intellectual property rules, the absence of manufacturing capacity in LMICs, and problems in the supply chain all contributed to this gap. To better …